Sinovac Biotech Ltd (SVA) — Tangible Net Worth Ratio
Sinovac Biotech Ltd (SVA) has a Tangible Net Worth Ratio of 97.8% as of June 2026. This metric is calculated by deducting intangible assets ($142.06 Million) from net assets ($6.46 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Sinovac Biotech Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sinovac Biotech Ltd Tangible Net Worth Ratio (1998–2025)
This chart shows how Sinovac Biotech Ltd's Tangible Net Worth Ratio has changed across 25 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 97.8%, reflecting net assets of $6.46 Billion with intangible assets of $142.06 Million USD. For live market cap and overall valuation, see Sinovac Biotech Ltd stock valuation.
Annual Tangible Net Worth Ratio for Sinovac Biotech Ltd (1998–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sinovac Biotech Ltd from 1998 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Sinovac Biotech Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.8% | $6.40 Billion | $77.68 Million | $8.64 Billion | ▲ +0.6 pp |
| 2024 | 98.2% | $10.29 Billion | $184.10 Million | $12.34 Billion | ▼ -1.7 pp |
| 2023 | 99.9% | $12.02 Billion | $8.52 Million | $13.66 Billion | ▲ +0.6 pp |
| 2022 | 99.4% | $12.71 Billion | $79.51 Million | $14.11 Billion | ▼ -0.3 pp |
| 2021 | 99.7% | $13.88 Billion | $41.21 Million | $16.75 Billion | ▲ +0.6 pp |
| 2020 | 99.1% | $1.12 Billion | $9.72 Million | $1.90 Billion | ▲ +1.4 pp |
| 2019 | 97.7% | $352.19 Million | $7.96 Million | $452.30 Million | ▲ +0.6 pp |
| 2018 | 97.2% | $291.93 Million | $8.30 Million | $369.78 Million | ▲ +3.9 pp |
| 2017 | 93.3% | $129.67 Million | $8.70 Million | $211.35 Million | ▲ +0.0 pp |
| 2016 | 93.3% | $129.67 Million | $8.70 Million | $211.35 Million | ▲ +0.3 pp |
| 2015 | 93.0% | $136.50 Million | $9.57 Million | $202.93 Million | ▲ +0.5 pp |
| 2014 | 92.5% | $141.73 Million | $10.61 Million | $238.53 Million | ▲ +0.7 pp |
| 2013 | 91.8% | $143.64 Million | $11.72 Million | $240.69 Million | ▲ +1.2 pp |
| 2012 | 90.7% | $129.44 Million | $12.06 Million | $208.76 Million | ▼ -8.4 pp |
| 2011 | 99.1% | $145.30 Million | $1.34 Million | $215.91 Million | ▼ 0.0 pp |
| 2010 | 99.1% | $147.76 Million | $1.35 Million | $214.36 Million | ▼ -0.1 pp |
| 2009 | 99.2% | $84.47 Million | $695.11K | $145.48 Million | ▲ +1.4 pp |
| 2008 | 97.8% | $53.64 Million | $1.19 Million | $77.44 Million | ▲ +2.0 pp |
| 2007 | 95.8% | $32.90 Million | $1.39 Million | $57.45 Million | ▲ +3.5 pp |
| 2006 | 92.2% | $21.31 Million | $1.65 Million | $37.01 Million | ▲ +6.4 pp |
| 2005 | 85.8% | $16.51 Million | $2.34 Million | $23.37 Million | ▼ -6.3 pp |
| 2004 | 92.1% | $15.56 Million | $1.23 Million | $22.42 Million | ▲ +15.4 pp |
| 2003 | 76.7% | $10.89 Million | $2.54 Million | $14.90 Million | ▲ +2289.6 pp |
| 2002 | -2212.9% | $99.44K | $2.30 Million | $236.25K | ▼ -2312.9 pp |
| 1998 | 100.0% | $29.01K | $0.00 | $33.51K | — |